Cardiovascular
Semaglutide Cardiovascular Outcomes Trial in Patients With Type 2 Diabetes
NN4473
Study Length: 3.5 – 5 years
Target Age/Sex: over 50 years of age, Male and Female
Participants will receive at no cost: study product, study materials and study-specific procedures
Link: ClinicalTrials.gov